Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the following new medicine which was referred to the Minister of Health under the provisions of section 24(5) of the Act and is set out in the Schedule hereto:
Schedule
Product: Ovidrel
Active Ingredient: Choriogonadotropin alfa 250µg
Dosage Form: Solution for injection
New Zealand Sponsor: Pharmacy Retailing (NZ) Ltd t/a Healthcare Logistics
Manufacturers: Industria Farmaceutica Serono SpA, Zona Industriale di Modugno, Bari, Italy
Laboratoires Serono SA, Zone Industrielle de l’Ouriettaz, Aubonne, Switzerland
Dated this 18th day of September 2008.
MARK RICHARDS, Deputy Director-General, Sector Accountability and Funding Directorate (pursuant to delegation given by the Minister of Health on 6 July 2001).